Farmacéuticos de Atención Primaria最新文献

{"title":"Nueva etapa, nuevos cambios","authors":"R. R. Guerrero","doi":"10.1016/S2172-3761(10)70001-7","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70001-7","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"1 1","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88793596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"","authors":"","doi":"10.1016/S2172-3761(10)70010-8","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70010-8","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"Pages 26-30"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70010-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71719465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diseño de un kit de medicación para el carro de parada de los Centros de Salud de un Área de Atención Primaria","authors":"M. Parramón Ponz ,&nbsp;A. Añino Alba ,&nbsp;C. Minguet Arenas ,&nbsp;O. Pinar López ,&nbsp;I. Fernández Esteban","doi":"10.1016/S2172-3761(10)70004-2","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70004-2","url":null,"abstract":"<div><p>A project in a Primary Care area of 887,134 inhabitants was conducted in order to select the essential medication to treat cardiorespiratory arrest. Furthermore, a supply and review circuit was designed. All of this is expressed in a standard operating procedure. The drugs selected were: adrenaline, amiodarone, atropine, sodium bicarbonate and glycosylated serum 5%, to be included in a transparent plastic case with an identification number and expiry date. A poster with information on the drugs, and request and review forms were designed. At present, almost all of the centers perform and document the revisions with the required periodicity. The circuits function correctly. No incident or notification of medication errors occurred. The professionals have manifested that they feel safer, due to the ease of management and safety that it provides.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"Pages 15-18"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70004-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Añadir famotidina al tratamiento con bajas dosis de ácido acetilsalicílico reduce la incidencia de úlceras gastroduodenales y esofagitis","authors":"D. Palma Morgado,&nbsp;B. Merino Rico,&nbsp;M.O. Caraballo Camacho","doi":"10.1016/S2172-3761(10)70005-4","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70005-4","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"19-20"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70005-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"El uso de rosuvastatina reduce la aparición de tromboembolismo venoso en personas sanas y frente a placebo","authors":"A. Rodríguez Terol,&nbsp;J. Cárdenas Gómez,&nbsp;D. Palma Morgado","doi":"10.1016/S2172-3761(10)70009-1","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70009-1","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"24-25"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70009-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71803556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Respuesta de los profesionales de medicina de familia a la difusión de la posible interacción entre clopidogrel y los inhibidores de la bomba de protones","authors":"M.A. García-Lirola ,&nbsp;L. González-García ,&nbsp;A. Ocaña Arenas ,&nbsp;E. Espínola García ,&nbsp;R. Díaz García ,&nbsp;J. Ortiz Espinosa","doi":"10.1016/S2172-3761(10)70002-9","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70002-9","url":null,"abstract":"<div><h3>Introduction</h3><p>Recently, different studies with contradictory results have been published on the possible interaction between clopidogrel and proton pump inhibitors (PPI). This study aims to analyze the response of the family medicine professionals in regards to modification in the treatment of patients using both drugs simultaneously after an intervention that consisted in the diffusion of the informative note issued by the Agencia Española de Medicamentos y Productos Sanitarios, accompanied by pharmacotherapeutical recommendations and census of the affected patients.</p></div><div><h3>Methods</h3><p>Before and after quasiexperimental study was performed by the Health Care District of Granada. The study population included the patients who were being prescribed both medications in June 2009, identified through the computer program MicroStrategy. A total of 1499 patients were detected through sampling stratified by center and by gender. A sample of 360 clinical histories was obtained. The audit was done on 298. The outcome variable was the modification or not of treatment classified according to the therapeutic option chosen (elimination or substitution of any of the drugs administered simultaneously).</p></div><div><h3>Results</h3><p>In 42.6% (95% CI: 37–48) of the clinical histories, the physician modified treatment after diffusion of the note. In 19.68% of the patients, treatment with clopidogrel was discontinued or substituted with acetylsalicylic acid (ASA). In the remaining 102 patients, the PPI was substituted with another drug or was withdrawn. In patients from teaching sites, more modifications of the treatment were made then in the nonteaching sites.</p></div><div><h3>Discussion</h3><p>The number of patients with both drugs prescribed simultaneously decreased. Thus the intervention is shown to be a valid option to be incorporated into the usual practice in the work of primary care pharmacists.</p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"Pages 2-6"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70002-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"En asma infantil no controlado con corticoides inhalados en dosis bajas, se debe individualizar el siguiente escalón","authors":"M.C. Vela Márquez ,&nbsp;A. Domínguez Recio ,&nbsp;C. Barreda Velásquez","doi":"10.1016/S2172-3761(10)70008-X","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70008-X","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"23-24"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70008-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71803557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Las indicaciones y marcas de los medicamentos genéricos","authors":"J.M. Paredero Domínguez","doi":"10.1016/S2172-3761(10)70003-0","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70003-0","url":null,"abstract":"<div><p>After the appearance on the generic drug market of active ingredients with significant impact on the National Health Care System invoicing, a debate has been opened on their indications and interchangeability for this reason. Simultaneously, the doubt also arises about the influence of the different excipients<span> or the different non-therapeutic fraction existing between reference medications and their corresponding generic ones. The differences in the indications are motivated by the second indication patent, together with the possibility of omitting the protected indications on the data sheet, as is contemplated in the regulation that regulates the authorization of the medication. On the other hand, the evaluation procedure assures that the differences in the non-therapeutic fraction of a drug (excipients, salt, esters, etc.) have been evaluated in regards to their toxicity, effect in pharmacokinetics and equivalent availability.</span></p></div>","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"Pages 7-14"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70003-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71828969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aspirina para diabéticos en prevención primaria: praxis sin evidencia científica","authors":"J. Rodríguez Castilla,&nbsp;M.C. Montero Balosa,&nbsp;D. Palma Morgado","doi":"10.1016/S2172-3761(10)70006-6","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70006-6","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"20-21"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70006-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71751751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dabigatrán y warfarina tienen similar eficacia y seguridad en pacientes con fibrilación auricular","authors":"D. Palma Morgado,&nbsp;E. Hevia Álvarez,&nbsp;C. Fernández Oropesa","doi":"10.1016/S2172-3761(10)70007-8","DOIUrl":"https://doi.org/10.1016/S2172-3761(10)70007-8","url":null,"abstract":"","PeriodicalId":100520,"journal":{"name":"Farmacéuticos de Atención Primaria","volume":"8 1","pages":"21-22"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2172-3761(10)70007-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71751752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}